Where does the Takeda Pharmaceuticals USA, Inc. case file come from?

Every entry is taken from the breach report Takeda Pharmaceuticals USA, Inc. lodged with the Texas Attorney General. Nothing here is estimated.

Why do the incident date and the report date differ?

Companies usually investigate before they report. The gap between the two dates shows how long that took.

What does the records-affected figure count?

It is the number the company gave the state. It can cover residents of that state only, so the national total may be higher.

Does this case file change over time?

Yes. When a company files an update or a new state publishes its copy of the report, the dates and counts here are refreshed.

Case file

Case File: Takeda Pharmaceuticals USA, Inc. Data Breach

This file collects the dated facts on record for the Takeda Pharmaceuticals USA, Inc. incident. The state report is dated June 26, 2026. The incident itself is dated February 9, 2026.

Timeline

137 days separate the incident date from the date it was reported.

February 9, 2026Incident dateWhen the filing says the breach took place.
June 26, 2026Report filed in TexasDate the notice was lodged with the Texas Attorney General.

Case facts

Filing state: Texas
Date reported: June 26, 2026
Incident date: February 9, 2026
Receiving office: Texas Attorney General

Case notes

Takeda Pharmaceuticals USA, Inc. has formally disclosed a data security incident. The company, which maintains a presence in Texas, reported this event through official channels, making details available in public filings.

The incident took place on February 9, 2026. Takeda Pharmaceuticals USA, Inc. subsequently filed its report regarding the event on June 26, 2026. The company has indicated that an investigation into the matter is currently underway.

While the company has confirmed a security incident, the specific categories of personal information affected were not detailed in the available public filing. This means the exact types of data involved remain unspecified in the record.

Individuals who have been notified by Takeda Pharmaceuticals USA, Inc. regarding this incident should review the information provided in their official communication. It is important to remain vigilant for any unusual activity related to your accounts or personal data.

General protective measures often include regularly reviewing statements from financial institutions for any unauthorized transactions. Additionally, it is advisable to monitor your credit reports for any new accounts or inquiries that you do not recognize.

Exercise caution with unsolicited communications, whether by email, phone, or mail, that request personal details. Always verify the legitimacy of such requests directly with the organization through official contact channels, not through links or numbers provided in the suspicious communication.

This information is based on the official data breach notifications made public by Takeda Pharmaceuticals USA, Inc. to regulatory bodies.

Questions about this case file

Where does the Takeda Pharmaceuticals USA, Inc. case file come from?: Every entry is taken from the breach report Takeda Pharmaceuticals USA, Inc. lodged with the Texas Attorney General. Nothing here is estimated.
Why do the incident date and the report date differ?: Companies usually investigate before they report. The gap between the two dates shows how long that took.
What does the records-affected figure count?: It is the number the company gave the state. It can cover residents of that state only, so the national total may be higher.
Does this case file change over time?: Yes. When a company files an update or a new state publishes its copy of the report, the dates and counts here are refreshed.

Texas data breaches

Filing source: Texas Attorney General

Named in the Takeda Pharmaceuticals USA, Inc. breach?

Attach your notice and a short note. An attorney checks it against this case file at no cost.

Timeline

Case facts

Case notes

Questions about this case file

More Texas case files